[1] |
Tameemi W A, Dale T P, Jumaily R M K A, et al.Hypoxia-modified cancer cell metabolism.Front. Cell Dev. Biol., 2019, 7:4.
|
[2] |
Pavlova N N, Thompson C B.The emerging hallmarks of cancer metabolism. Cell Metab., 2016, 23(1):27-47.
|
[3] |
Liberti M V, Locasale J W.The Warburg Effect: How does it benefit cancer cells?. Trends Biochem. Sci., 2016,41(3):211-218.
|
[4] |
Birsoy K, Possemato R, Lorbeer F K, et al.Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature, 2014,508(7494):108-112.
|
[5] |
Zeng P, Sun S N, Li R, et al. HER2 upregulates ATF4 to promote cell migration via activation of ZEB1 and downregulation of E-cadherin. Int. J. Mol. Sci., 2019,20(9):2223
|
[6] |
Zong Y, Feng S J, Cheng J W, et al.Up-regulated ATF4 expression increases cell sensitivity to apoptosis in response to radiation. Cell. Physiol. Biochem., 2017,41(2):784-794.
|
[7] |
Gwinn D M, Lee A G,Campo M B M D, et al.Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-asparaginase. Cancer Cell, 2018,33(1):91-107.e6.
|
[8] |
Rozpedek W, Pytel D, Mucha B, et al. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr. Mol. Med., 2016,16(6):533-544.
|
[9] |
Tang Q,Ren L W, Liu J Y, et al. Withaferin a triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis. Cell Prolif., 2020,53(1):e12706.
|
[10] |
Liu H C, Chao X, Liu J W, et al.Aspirin exerts anti-tumor effect through inhibiting Blimp1 and activating ATF4/CHOP pathway in multiple myeloma. Biomed. Pharmacother., 2020,125:110005.
|
[11] |
Iurlaro R, Püschel F, Annicchiarico C L L,et al. Glucose deprivation induces ATF4-mediated apoptosis through TRAIL death receptors. Mol. Cell. Biol., 2017,37(10): e00479-16.
|
[12] |
Dayton T L, Jacks T, Heiden M G V.PKM2, cancer metabolism, and the road ahead. EMBO Rep., 2016,17(12):1721-1730.
|
[13] |
Taguchi K, Yamamoto M.The KEAP1-NRF2 system in cancer. Front Oncol., 2017,7:85.
|
[14] |
Qian X Y, Zhao J Y, Yeung P Y, et al.Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem. Sci., 2019,44(1):33-52.
|
[15] |
Jathar S,Kumar V, Srivastava J,et al. Technological developments in lncRNA biology. Adv. Exp. Med. Biol., 2017,1008:283-323.
|
[16] |
Liu Y,Yang Y L,Li L, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochem. Cell Biol.,2018,96(1):38-43.
|
[17] |
Liu C Y, Zhang Y H, Li R B, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat. Commun., 2018,9(1):29.
|
[18] |
Chen L, Yang W J, Guo Y J, et al. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS One, 2017, 12(9):e0185406.
|
[19] |
Kern C, Wang Y, Chitwood J, et al.Genome-wide identification of tissue-specific long non-coding RNA in three farm animal species. BMC Genomics, 2018,19(1):684.
|
[20] |
Zhu J,Kong F Y, Xing L, et al. Prognostic and clinicopathological value of long noncoding RNA XIST in cance. Clin. Chim. Acta, 2018,479:43-47.
|
[21] |
Dang Y, Lan F H, Ouyang X J,et al. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer. World J. Surg. Oncol., 2015,13:302.
|
[22] |
Lu D P, Luo P, Wang Q, et al. lncRNA PVT1 in cancer: A review and meta-analysis. Clin Chim Acta, 2017, 474:1-7.
|
[23] |
Han P, Li J W, Zhang B M, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol. Cancer, 2017, 16(1):9.
|
[24] |
Ma T T,Zhou L Q, Xia J H, et al.LncRNA PCAT-1 regulates the proliferation, metastasis and invasion of cervical cancer cells. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(7):1907-1913.
|
[25] |
Hartke J,Johnson M, Ghabril M.The diagnosis and treatment of hepatocellular carcinoma. Semin. Diagn. Pathol., 2017, 34(2):153-159.
|
[26] |
Ko K L, Mak L Y, Cheung K S,et al. Hepatocellular carcinoma: Recent advances and emerging medical therapies. F1000Res., 2020, 9:F1000 Faculty Rev-620.
|
[27] |
Craig A J, Felden J V, Lezana T G, et al.Tumour evolution in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol., 2020, 17(3):139-152.
|
[28] |
Adams C M, Ebert S M, Dyle M C.Role of ATF4 in skeletal muscle atrophy. Curr. Opin. Clin. Nutr. Metab. Care, 2017, 20(3):164-168.
|
[29] |
Bader J E, Voss K, Rathmell J C.Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol. Cell, 2020, 78(6):1019-1033.
|
[30] |
Li X X, Wang Z J,Zheng Y, et al.Nuclear receptor Nur77 facilitates melanoma cell survival under metabolic stress by protecting fatty acid oxidation. Mol. Cell, 2018, 69(3):480-492.e7.
|
[31] |
Ye J B, Kumanova M,Hart L S, et al.The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J., 2010, 29(12):2082-2096.
|
[32] |
Dey S,Sayers C M, Verginadis I I, et al. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J. Clin. Invest., 2015, 125(7):2592-2608.
|
[33] |
Han J, Back S H, Hur J, et al.ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol., 2013, 15(5):481-490.
|
[34] |
Xiao Z D, Han L, Lee H, et al.Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat. Commun., 2017, 8(1):783.
|
[35] |
Liu X W, Xia Z D,Han L, et al.LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat. Cell Biol., 2016, 18(4):431-442.
|
[1] |
Tameemi W A, Dale T P, Jumaily R M K A, et al.Hypoxia-modified cancer cell metabolism.Front. Cell Dev. Biol., 2019, 7:4.
|
[2] |
Pavlova N N, Thompson C B.The emerging hallmarks of cancer metabolism. Cell Metab., 2016, 23(1):27-47.
|
[3] |
Liberti M V, Locasale J W.The Warburg Effect: How does it benefit cancer cells?. Trends Biochem. Sci., 2016,41(3):211-218.
|
[4] |
Birsoy K, Possemato R, Lorbeer F K, et al.Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature, 2014,508(7494):108-112.
|
[5] |
Zeng P, Sun S N, Li R, et al. HER2 upregulates ATF4 to promote cell migration via activation of ZEB1 and downregulation of E-cadherin. Int. J. Mol. Sci., 2019,20(9):2223
|
[6] |
Zong Y, Feng S J, Cheng J W, et al.Up-regulated ATF4 expression increases cell sensitivity to apoptosis in response to radiation. Cell. Physiol. Biochem., 2017,41(2):784-794.
|
[7] |
Gwinn D M, Lee A G,Campo M B M D, et al.Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-asparaginase. Cancer Cell, 2018,33(1):91-107.e6.
|
[8] |
Rozpedek W, Pytel D, Mucha B, et al. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr. Mol. Med., 2016,16(6):533-544.
|
[9] |
Tang Q,Ren L W, Liu J Y, et al. Withaferin a triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis. Cell Prolif., 2020,53(1):e12706.
|
[10] |
Liu H C, Chao X, Liu J W, et al.Aspirin exerts anti-tumor effect through inhibiting Blimp1 and activating ATF4/CHOP pathway in multiple myeloma. Biomed. Pharmacother., 2020,125:110005.
|
[11] |
Iurlaro R, Püschel F, Annicchiarico C L L,et al. Glucose deprivation induces ATF4-mediated apoptosis through TRAIL death receptors. Mol. Cell. Biol., 2017,37(10): e00479-16.
|
[12] |
Dayton T L, Jacks T, Heiden M G V.PKM2, cancer metabolism, and the road ahead. EMBO Rep., 2016,17(12):1721-1730.
|
[13] |
Taguchi K, Yamamoto M.The KEAP1-NRF2 system in cancer. Front Oncol., 2017,7:85.
|
[14] |
Qian X Y, Zhao J Y, Yeung P Y, et al.Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem. Sci., 2019,44(1):33-52.
|
[15] |
Jathar S,Kumar V, Srivastava J,et al. Technological developments in lncRNA biology. Adv. Exp. Med. Biol., 2017,1008:283-323.
|
[16] |
Liu Y,Yang Y L,Li L, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochem. Cell Biol.,2018,96(1):38-43.
|
[17] |
Liu C Y, Zhang Y H, Li R B, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat. Commun., 2018,9(1):29.
|
[18] |
Chen L, Yang W J, Guo Y J, et al. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS One, 2017, 12(9):e0185406.
|
[19] |
Kern C, Wang Y, Chitwood J, et al.Genome-wide identification of tissue-specific long non-coding RNA in three farm animal species. BMC Genomics, 2018,19(1):684.
|
[20] |
Zhu J,Kong F Y, Xing L, et al. Prognostic and clinicopathological value of long noncoding RNA XIST in cance. Clin. Chim. Acta, 2018,479:43-47.
|
[21] |
Dang Y, Lan F H, Ouyang X J,et al. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer. World J. Surg. Oncol., 2015,13:302.
|
[22] |
Lu D P, Luo P, Wang Q, et al. lncRNA PVT1 in cancer: A review and meta-analysis. Clin Chim Acta, 2017, 474:1-7.
|
[23] |
Han P, Li J W, Zhang B M, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol. Cancer, 2017, 16(1):9.
|
[24] |
Ma T T,Zhou L Q, Xia J H, et al.LncRNA PCAT-1 regulates the proliferation, metastasis and invasion of cervical cancer cells. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(7):1907-1913.
|
[25] |
Hartke J,Johnson M, Ghabril M.The diagnosis and treatment of hepatocellular carcinoma. Semin. Diagn. Pathol., 2017, 34(2):153-159.
|
[26] |
Ko K L, Mak L Y, Cheung K S,et al. Hepatocellular carcinoma: Recent advances and emerging medical therapies. F1000Res., 2020, 9:F1000 Faculty Rev-620.
|
[27] |
Craig A J, Felden J V, Lezana T G, et al.Tumour evolution in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol., 2020, 17(3):139-152.
|
[28] |
Adams C M, Ebert S M, Dyle M C.Role of ATF4 in skeletal muscle atrophy. Curr. Opin. Clin. Nutr. Metab. Care, 2017, 20(3):164-168.
|
[29] |
Bader J E, Voss K, Rathmell J C.Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol. Cell, 2020, 78(6):1019-1033.
|
[30] |
Li X X, Wang Z J,Zheng Y, et al.Nuclear receptor Nur77 facilitates melanoma cell survival under metabolic stress by protecting fatty acid oxidation. Mol. Cell, 2018, 69(3):480-492.e7.
|
[31] |
Ye J B, Kumanova M,Hart L S, et al.The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J., 2010, 29(12):2082-2096.
|
[32] |
Dey S,Sayers C M, Verginadis I I, et al. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J. Clin. Invest., 2015, 125(7):2592-2608.
|
[33] |
Han J, Back S H, Hur J, et al.ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol., 2013, 15(5):481-490.
|
[34] |
Xiao Z D, Han L, Lee H, et al.Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat. Commun., 2017, 8(1):783.
|
[35] |
Liu X W, Xia Z D,Han L, et al.LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat. Cell Biol., 2016, 18(4):431-442.
|